ATE472996T1 - Cefquinomzusammensetzungen und verfahren zu ihrer verwendung - Google Patents
Cefquinomzusammensetzungen und verfahren zu ihrer verwendungInfo
- Publication number
- ATE472996T1 ATE472996T1 AT06851366T AT06851366T ATE472996T1 AT E472996 T1 ATE472996 T1 AT E472996T1 AT 06851366 T AT06851366 T AT 06851366T AT 06851366 T AT06851366 T AT 06851366T AT E472996 T1 ATE472996 T1 AT E472996T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- cefquinome
- methods
- kits
- making
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- YWKJNRNSJKEFMK-PQFQYKRASA-N (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-(5,6,7,8-tetrahydroquinolin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound N([C@@H]1C(N2C(=C(C[N+]=3C=4CCCCC=4C=CC=3)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 YWKJNRNSJKEFMK-PQFQYKRASA-N 0.000 title abstract 2
- 229950009592 cefquinome Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73146305P | 2005-10-29 | 2005-10-29 | |
| EP06111029 | 2006-03-13 | ||
| PCT/US2006/041952 WO2007145656A2 (en) | 2005-10-29 | 2006-10-27 | Cefquinome compositions and methods of their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE472996T1 true ATE472996T1 (de) | 2010-07-15 |
Family
ID=37728210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06851366T ATE472996T1 (de) | 2005-10-29 | 2006-10-27 | Cefquinomzusammensetzungen und verfahren zu ihrer verwendung |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20080318919A1 (de) |
| EP (1) | EP1945223B1 (de) |
| JP (1) | JP5322649B2 (de) |
| AT (1) | ATE472996T1 (de) |
| CA (1) | CA2626273C (de) |
| ES (1) | ES2346573T3 (de) |
| PL (1) | PL1945223T3 (de) |
| PT (1) | PT1945223E (de) |
| WO (1) | WO2007145656A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR077320A1 (es) * | 2009-07-20 | 2011-08-17 | Intervet Int Bv | Metodo para la preparacion de particulas de cefquinoma y formulaciones farmaceuticas que las comprenden. |
| MX2013012820A (es) | 2011-05-02 | 2014-02-10 | Zoetis Llc | Cefalosporinas novedosas utiles como agentes antibacteriales. |
| CN105079000B (zh) * | 2015-09-22 | 2018-07-06 | 佛山市南海东方澳龙制药有限公司 | 一种组合物及其应用、制剂 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1380741A (en) * | 1971-02-05 | 1975-01-15 | Squibb & Sons Inc | Antibiotic compositions and their preparation |
| DE3706020A1 (de) * | 1987-02-25 | 1988-09-08 | Hoechst Ag | Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung |
| JPH0662419B2 (ja) * | 1987-12-04 | 1994-08-17 | 武田薬品工業株式会社 | 抗生物質組成物 |
| DE3909056A1 (de) * | 1989-03-18 | 1990-09-20 | Hoechst Ag | Pharmazeutische kombinationspraeparate und deren verwendung zur prophylaxe oder behandlung bakterieller infektionskrankheiten |
| DE4440141A1 (de) * | 1994-11-10 | 1996-05-15 | Hoechst Ag | Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung |
| TWI265654B (en) * | 2001-11-21 | 2006-11-01 | Polyfuel Inc | Catalyst agglomerates for membrane electrode assemblies |
| US7378408B2 (en) * | 2001-11-30 | 2008-05-27 | Pfizer Inc. | Methods of treatment and formulations of cephalosporin |
| EP1585497B1 (de) * | 2002-12-16 | 2008-03-26 | Intervet International BV | Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin |
| JP4700291B2 (ja) * | 2003-04-28 | 2011-06-15 | 武田薬品工業株式会社 | 注射用組成物 |
-
2006
- 2006-10-27 CA CA2626273A patent/CA2626273C/en not_active Expired - Fee Related
- 2006-10-27 EP EP06851366A patent/EP1945223B1/de active Active
- 2006-10-27 AT AT06851366T patent/ATE472996T1/de active
- 2006-10-27 WO PCT/US2006/041952 patent/WO2007145656A2/en not_active Ceased
- 2006-10-27 ES ES06851366T patent/ES2346573T3/es active Active
- 2006-10-27 JP JP2008537983A patent/JP5322649B2/ja active Active
- 2006-10-27 US US12/090,416 patent/US20080318919A1/en not_active Abandoned
- 2006-10-27 PT PT06851366T patent/PT1945223E/pt unknown
- 2006-10-27 PL PL06851366T patent/PL1945223T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL1945223T3 (pl) | 2010-12-31 |
| JP5322649B2 (ja) | 2013-10-23 |
| WO2007145656A2 (en) | 2007-12-21 |
| EP1945223A4 (de) | 2009-11-25 |
| JP2009513665A (ja) | 2009-04-02 |
| ES2346573T3 (es) | 2010-10-18 |
| US20080318919A1 (en) | 2008-12-25 |
| CA2626273C (en) | 2013-05-14 |
| PT1945223E (pt) | 2010-10-14 |
| CA2626273A1 (en) | 2007-12-21 |
| WO2007145656A3 (en) | 2008-08-14 |
| EP1945223A2 (de) | 2008-07-23 |
| EP1945223B1 (de) | 2010-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201070247A1 (ru) | Ингибиторы протеасом | |
| JO2778B1 (en) | Certain Compounds, Compositions and Methods | |
| PA8842101A1 (es) | Heteroarilos sustituidos | |
| DK1853602T3 (da) | Kemiske forbindelser | |
| CY1108275T1 (el) | Χημικες ενωσεις | |
| EA201100094A1 (ru) | Тиадиазолилоксифениламидины и их применение в качестве фунгицидов | |
| EA201170295A1 (ru) | ИНГИБИТОРЫ сМЕТ | |
| NO20090313L (no) | Derivater og analoger av N-etylkinoloner og N-etylazakinoloner | |
| WO2007092622A3 (en) | Compositions and methods for treating bone | |
| NO20084007L (no) | Spirokondenserte piperidiner som modulatorer av muskarinreseptorer | |
| CY1109568T1 (el) | Ενωσεις βενζο(d)ισοξαζολ-3-υλαμινης και η χρησιμοποιηση τους σαν προσδεματα υποδοχεα βανιλλοειδων | |
| ATE433447T1 (de) | Pyrimiidinverbindungen | |
| GT200600035A (es) | Aminopiridinas como inhibidores de beta-secretasa | |
| WO2007150015A3 (en) | Method of treatment | |
| NO20090157L (no) | Tienpyrimidiner anvendelige som modulatorer av ionekanaler | |
| EA201000915A1 (ru) | Ингибиторы пролилгидроксилазы | |
| ATE553104T1 (de) | Substituierte 1h-benzimidazol-4-carboxamide als potente parp-hemmer | |
| WO2007097981A3 (en) | Alpha carbolines and uses thereof | |
| EA201001481A1 (ru) | Производные третичного амина в качестве ингибиторов фосфодиэстеразы-4 | |
| NO20083751L (no) | Metoder for behandling av kognitive og andre sykdommer | |
| ATE517900T1 (de) | Heptarylen-und octarylentetracarbonsäurediimide und deren herstellung | |
| SE0403086D0 (sv) | Compounds | |
| ATE544455T1 (de) | Zusammensetzungen und verfahren für die krebsbehandlung | |
| NO20074528L (no) | Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme | |
| ATE496914T1 (de) | Verfahren zur synthese von triazolen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1945223 Country of ref document: EP |